Abiopharma

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015531 <b>Size:</b> 1 MB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0001140361-26-015528 <b>Size:</b> 442 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-04-20 <b>AccNo:</b> 0000950103-26-005925 <b>Size:</b> 378 KB

BRASKEM SA (BAK) Files Form 6-K

Report of control means as of 31.3.26

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Net Asset Value(s)

SWVL HOLDINGS CORP (SWVLW) Files Form 6-K

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

(99% Positive) WORKSPORT LTD (WKSP) Files Form 8-K

(99% Neutral) AST SPACEMOBILE, INC. (ASTS) Files Form 8-K

(100% Positive) BIO KEY INTERNATIONAL INC (BKYI) Reports Q2 2026 Financial Results

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Files Form 6-K

PINNACLE FOOD GROUP LTD (PFAI) Files Form 6-K

Abrams Capital Acquires Additional Shares of SECURE Waste Infrastructure Corp.